High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
about
How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?Expression of CCR9 in HTLV-1+ T cells and ATL cells expressing TaxPlasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesisImmunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathyIn vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disordersZidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.Retroviral spread by induction of virological synapses.Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.Cellular Factors Involved in HTLV-1 Entry and PathogenicitImmunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectivesHuman RNA "rumor" viruses: the search for novel human retroviruses in chronic diseaseDysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease.Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo.Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm.CTL quality and the control of human retroviral infections.Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.HTLV-1-associated infective dermatitis: updates on the pathogenesis.Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.The HTLV-1 Virological Synapse.Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy.High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease.Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.Human T-cell leukaemia virus type 1: parasitism and pathogenesis.In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.HTLV-1-associated myelopathy/tropical spastic paraparesis.HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.IFNG +874A/T Polymorphism Among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis.
P2860
Q26785554-AE3E5189-3108-4EA0-A4E0-9D27E240ED45Q28282016-22D37671-5829-4C8F-8401-434032E97264Q31033564-AE7955D8-6CE9-4C4C-B34C-2CAD3D054FECQ33355836-795D8C28-816A-4021-B15F-F883864B8A62Q33651831-EAE6EBE1-B312-4EFD-99CC-8385917887BCQ33713794-BE7EAA47-F9A4-426B-9277-A9D257CE2BBFQ34145669-5628EE90-1C1E-4A41-8B4F-D900F9D01395Q34359754-EE540BAF-FE81-4CA0-9F82-6A8A19A59073Q34764429-AB7473BE-CFEB-447E-818D-994907B3F3F4Q34927431-7187B14D-EB0A-4B93-A909-5779A2201972Q35065987-6AB8EED9-F1EF-4CFC-9436-228EF8E71648Q35139637-22448C60-6D09-47A9-90C4-712C84748774Q35856741-7CD6CBF3-9F2D-460F-BE3C-81909F5E44F4Q35891748-DD85E793-39E1-46CF-A5CE-E48F93DB6164Q35989638-2673EA30-E71D-4001-B412-804CA42D7509Q36049779-AB303959-B841-45FF-816F-F80186646827Q36422111-4E576172-F4C6-4149-A011-03CF049A70A5Q36497719-9FAD8E32-E566-454A-8860-EBB5635222E7Q36713538-545AD64C-6B4F-4CF3-89D8-021DED7C44FCQ36735681-53E8D7D6-239F-402A-BD27-80D80CB7A021Q36974698-031DCFD8-358E-4E91-BBAB-04F70ECA74CFQ37543246-D93FF9AF-8D25-4333-B912-22B430D376E2Q37568028-05B2B25F-0CBB-422A-9F31-03CF5B02035FQ38060839-A251F1EB-CDE3-496F-9588-4B71E58DB78FQ38128799-1E06E112-55AF-4F17-8466-F851B73D204EQ38615502-25D2614B-9144-41D5-82A2-E879899F99B2Q38874995-289C8A16-86A8-4FB4-ABA3-4224302C40C1Q39028778-BE5867B8-84BC-440E-8A07-F8A862A97F25Q39035579-14218B1C-F099-4B23-B38F-9B892C8AD05BQ39167266-15F934EA-34D3-47D2-B108-2EE0E9B8494BQ39167464-17526633-33C8-4D30-BFF5-27CD6679D9DCQ39377294-454FBD97-7374-493E-A902-41BF5C554CB9Q39487416-739ABF17-BAB7-4CEC-8C7B-BE60E906295EQ40046615-A864924B-A63B-4A9C-9769-6C96B49155C4Q40267146-24D36E35-1032-46B9-9CE2-CB1CF4795E3CQ45096240-7D487E7C-4E13-439A-B033-034E0D9C56DCQ47562043-F883A130-4C80-49F0-9CF9-026AE70CD0D7Q54957634-8DF5D81B-68CE-490B-8BE4-90CEEE7EE266Q54977276-71D4AFBC-E7A3-44C3-A06F-1C2078E68154
P2860
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
High frequencies of Th1-type CD4
@nl
High frequencies of Th1-type C ...... /tropical spastic paraparesis.
@en
type
label
High frequencies of Th1-type CD4
@nl
High frequencies of Th1-type C ...... /tropical spastic paraparesis.
@en
prefLabel
High frequencies of Th1-type CD4
@nl
High frequencies of Th1-type C ...... /tropical spastic paraparesis.
@en
P2093
P356
P1433
P1476
High frequencies of Th1-type C ...... /tropical spastic paraparesis.
@en
P2093
Charles R M Bangham
Emmanuel Hanon
Graham P Taylor
Jonathan N Weber
Peter K C Goon
Tadahiko Igakura
P304
P356
10.1182/BLOOD.V99.9.3335
P407
P577
2002-05-01T00:00:00Z